Public-registry trials using Icosapent Ethyl Oral Capsule that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia | Zhejiang Doer Biologics Co., Ltd. | Severe Hypertriglyceridemia | PHASE3 | 1 |
| First registered study | October 2003 — NCT00069784 (Sanofi) |
| Registered studies matching this name | 15 all-time · 1 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Severe Hypertriglyceridemia studies · Weekly briefs